SAN FRANCISCO, April 23, 2025--(BUSINESS WIRE)--Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced new clinical data validating the accuracy and ...
ABU DHABI, UAE — In the past 9 months, a surge of new trials related to the management of intracranial hemorrhage (ICH) has led the European Stroke Organisation (ESO) to delay issuing a planned ...
Patients with acute intracerebral hemorrhage who are receiving factor Xa inhibitors have a risk of hematoma expansion. The effect of andexanet alfa, an agent that reverses the effects of factor Xa ...
Real-world evidence supports Viz ICH Plus for reliable volume and midline shift estimation SAN FRANCISCO, April 23, 2025--(BUSINESS WIRE)--Viz.ai, the leader in AI-powered disease detection and ...